Pharmacovigilance and Risk Management Strategies Conference

Featured

Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Short Course or Primer

To keep you at the forefront.

2020 年 01 月 26 日

Short Course 1:

Pharmacovigilance and Risk Management Planning

了解更多

2020 年 01 月 26 日

Short Course 2:

Interdisciplinary Safety Evaluation During Product Development

了解更多

2020 年 01 月 26 日

Short Course 3:

Reference Safety Information

了解更多

2020 年 01 月 26 日

Short Course 4:

Introduction to Statistics in Pharmacovigilance

了解更多

2020 年 01 月 26 日

Short Course 5:

Pharmacovigilance for Medication Errors

了解更多

2020 年 01 月 26 日

Short Course 1:

Pharmacovigilance and Risk Management Planning

了解更多

2020 年 01 月 26 日

Short Course 2:

Interdisciplinary Safety Evaluation During Product Development

了解更多

2020 年 01 月 26 日

Short Course 3:

Reference Safety Information

了解更多

2020 年 01 月 26 日

Short Course 4:

Introduction to Statistics in Pharmacovigilance

了解更多

2020 年 01 月 26 日

Short Course 5:

Pharmacovigilance for Medication Errors

了解更多

项目委员会

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom
William Gregory, PhD Senior Director, Safety and Risk Management
Pfizer Inc, United States
Catherine Baldridge, MSc Head of Safety
Fusion Pharmaceuticals, United States
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States
Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
FDA, United States
Ingrid N. Chapman, PharmD Senior Risk Management Analyst, DRM, OMEPRM, OSE, CDER
FDA, United States
Mick Foy Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States
Jill K. Logan, PharmD Safety Evaluator, DPV I, OSE, CDER
FDA, United States
Barbara Morollo, RN Head, Pharmacovigilance
Corbus Pharmaceuticals, United States
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
UBC, United States
Lesley Wise, PhD, MSc Managing Director
Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom
Hui-Lee Wong, PhD, MS Epidemiologist, Sentinel Central Team, OBE, CBER
FDA, United States
Jo Wyeth, PharmD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
FDA, United States